Faecal calprotectin and gut microbiota do not predict enteropathy in very preterm infants.

Aim: Very preterm birth is associated with a high risk of enteropathies. Diagnosis is challenging, especially in mild forms, leading to unnecessary periods of cessation of enteral feeding. This study aimed at establishing a prognosis score of enteropathy combining clinical parameters and faecal calprotectin concentration.

Antenatal antipsychotic exposure induces multigenerational and gender-specific programming of adiposity and glucose tolerance in adult mouse offspring.

Second-generation antipsychotics (SGAs) are well known for their metabolic side effects in humans, including obesity and diabetes. These compounds are maintained during pregnancy to prevent the relapse of psychoses, but they readily diffuse across the placenta to the fetus, as documented with the widely-prescribed drug olanzapine (OLZ). However, observational studies have provided conflicting results on the potential impact of SGAs on fetal growth and body weight, and their effects on metabolic regulation in the offspring.

[Nutrition and growth follow-up in the preterm infant].

The nutrition of premature babies is an important issue to improve their short and long-term growth and development. After birth, our target is to achieve the same growth as a foetus of similar gestational age. The recent recommendations insist on the early introduction of enteral and parenteral nutrition, with optimization of protein and energy intakes to avoid the appearance of extra-uterine failure to thrive.

[Perinatal management and neurological outcome of newborns hospitalized with Rhesus hemolytic disease].

Objectives: To evaluate perinatal management and neurological outcome in a group of infants born with Rhesus fetomaternal allo-immunization.

Patients And Methods: Between 1 January and 31 December 2005, all newborns admitted to neonatal unit of Rouen tertiary centre for Rhesus hemolytic disease were included in a retrospective study and divided in two groups. The newborns who were treated with intrauterine transfusion are in the group 1 and those who needed only postnatal treatment in the group 2.